Cargando…
High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease
BACKGROUND: The molecular aetiology of inflammatory bowel disease [IBD] and its two subtypes, ulcerative colitis [UC] and Crohn’s disease [CD], have been carefully investigated at genome and transcriptome levels. Recent advances in high-throughput proteome quantification has enabled comprehensive la...
Autores principales: | Di Narzo, Antonio F, Brodmerkel, Carrie, Telesco, Shannon E, Argmann, Carmen, Peters, Lauren A, Li, Katherine, Kidd, Brian, Dudley, Joel, Cho, Judy, Schadt, Eric E, Kasarskis, Andrew, Dobrin, Radu, Hao, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441306/ https://www.ncbi.nlm.nih.gov/pubmed/30445421 http://dx.doi.org/10.1093/ecco-jcc/jjy190 |
Ejemplares similares
-
High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic Factors
por: Di Narzo, Antonio F., et al.
Publicado: (2017) -
Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn's Disease Cohort Inform IBD Genetic Association Loci
por: Di Narzo, Antonio F, et al.
Publicado: (2016) -
A functional genomics predictive network model identifies regulators of inflammatory bowel disease
por: Peters, Lauren A, et al.
Publicado: (2017) -
Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
por: Doherty, Matthew K., et al.
Publicado: (2018) -
A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients
por: Peters, Lauren A., et al.
Publicado: (2023)